Status:
RECRUITING
SIMPLIFication of Care Pathways for Patients with Rare Brain Tumors Through Artificial Intelligence
Lead Sponsor:
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Collaborating Sponsors:
ASL 1 Avezzano Sulmona L'Aquila
Conditions:
Brain Tumors
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study focuses on rare brain tumors, which are heterogeneous entities with different morphological, biological, and clinical characteristics. Due to their rarity, many of these tumors fall under t...
Detailed Description
Participants will be adults with rare brain tumors and will be enrolled at two neurosurgery centers in Italy. The study aims to create a network of professionals specialized in predicting surgical out...
Eligibility Criteria
Inclusion
- Adults (age ≥18 years)
- Both sexes
- Patients with rare brain tumors (incidence \<6 cases per 100,000 people/year)
- Candidates for craniotomy for rare brain tumors
- Native Italian speakers for cognitive and psychological evaluation and neuro-cognitive rehabilitation
Exclusion
- Patients undergoing stereotactic/frameless biopsy
- Patients with psychiatric disorders or on psychotropic medications
- Patients with known cognitive decline (not due to the lesion)
- Patients admitted on the same day as the surgery
- Patients with severe impairments referred to rehabilitation centers
- Patients without a Windows PC or laptop with Internet connection for neuro-cognitive rehabilitation
Key Trial Info
Start Date :
January 27 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06878469
Start Date
January 27 2025
End Date
July 1 2026
Last Update
March 17 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione IRCCS Istituto Neurologico Carlo Besta
Milan, PA, Italy, 20133
2
ASL 1 Abruzzo Avezzano-Sulmona-L'Aquila
L’Aquila, Italy, 67100